mRNA-based therapeutics--developing a new class of drugs

Sahin, Ugur, Karikó, Katalin, Türeci, Özlem·2014·Nature Reviews Drug Discovery

Cited by (1,005)

Items 201–300 of 1,005

  1. Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy
    Yugang Guo, Kewen Lei, Li Tang · 2018 · Frontiers in Immunology
  2. Systemic delivery of messenger RNA for the treatment of pancreatic cancer using polyplex nanomicelles with a cholesterol moiety
    Satoshi Uchida, Hiroaki Kinoh, Takehiko Ishii, Akitsugu Matsui, Theofilus A. Tockary, Kaori M. Takeda, Hirokuni Uchida, Kensuke Osada, Keiji Itaka, Kazunori Kataoka · 2015 · Biomaterials
  3. Extracellular vesicles for nucleic acid delivery: progress and prospects for safe RNA-based gene therapy
    Linglei Jiang, Pieter Vader, Raymond Michel Schiffelers · 2017 · Gene Therapy
  4. ADAR RNA Modifications, the Epitranscriptome and Innate Immunity
    Jaclyn E. Quin, Jiří Sedmík, Dragana Vukić, Anzer Khan, Liam P. Keegan, Mary A. O’Connell · 2021 · Trends in Biochemical Sciences
  5. Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice
    Jamile Ramos da Silva, Karine Bitencourt Rodrigues, Guilherme Formoso Pelegrin, Natiely Silva Sales, Hiromi Muramatsu, Mariângela de Oliveira Silva, Bruna F.M.M. Porchia, Ana Carolina Ramos Moreno, Luana R. M. M. Aps, Aléxia Adrianne Venceslau-Carvalho et al. · 2023 · Science Translational Medicine
  6. mRNA vaccine in cancer therapy: Current advance and future outlook
    Youhuai Li, Mina Wang, Xueqiang Peng, Yingying Yang, Qishuang Chen, Jiaxing Liu, Qing She, Jichao Tan, Chuyuan Lou, Zehuan Liao et al. · 2023 · Clinical and Translational Medicine
  7. Tailor made: the art of therapeutic mRNA design
    Mihir Metkar, Christopher S. Pepin, Melissa J. Moore · 2023 · Nature Reviews Drug Discovery
  8. Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency
    Prieve, Mary G., Harvie, Pierrot, Monahan, Sean D., Roy, Debashish, Li, Allen G., Blevins, Teri L., Paschal, Amber E., Waldheim, Matt, Bell, Eric C., Galperin, Anna et al. · 2018 · Molecular Therapy
  9. Focused ultrasound/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain
    Ogawa, Koki, Kato, Naoya, Yoshida, Michiharu, Hiu, Takeshi, Matsuo, Takayuki, Mizukami, Shusaku, Omata, Daiki, Suzuki, Ryo, Maruyama, Kazuo, Mukai, Hidefumi et al. · 2022 · Journal of Controlled Release
  10. The use of RNA-based treatments in the field of cancer immunotherapy
    Mohammad Chehelgerdi, Matin Chehelgerdi · 2023 · Molecular Cancer
  11. Translational precision medicine: an industry perspective
    Dominik Hartl, Valéria De Luca, Anna Kostikova, Jason M. Laramie, Scott Kennedy, Enrico Ferrero, Richard W. Siegel, Martin Fink, Sohail Ahmed, John M. Millholland et al. · 2021 · Journal of Translational Medicine
  12. The identity and methylation status of the first transcribed nucleotide in eukaryotic mRNA 5’ cap modulates protein expression in living cells
    Sikorski, Pawel J, Warminski, Marcin, Kubacka, Dorota, Ratajczak, Tomasz, Nowis, Dominika, Kowalska, Joanna, Jemielity, Jacek · 2020 · Nucleic Acids Research
  13. mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice
    Ole Audun Werner Haabeth, Timothy R. Blake, Colin J. McKinlay, Robert M. Waymouth, Paul A. Wender, Ronald Levy · 2018 · Proceedings of the National Academy of Sciences
  14. Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes
    Lien Van Hoecke, Sandra Van Lint, Kenny Roose, Alexander Van Parys, Peter Vandenabeele, Johan Grooten, Jan H. Tavernier, Stefaan De Koker, Xavier Saelens · 2018 · Nature Communications
  15. Non-viral delivery of the CRISPR/Cas system: DNA versus RNA versus RNP
    Yi Lin, Ernst Wagner, Ulrich Lächelt · 2022 · Biomaterials Science
  16. mRNA in the Context of Protein Replacement Therapy
    Theofanis Vavilis, Εleni Stamoula, Alexandra Ainatzoglou, Athanasios Sachinidis, Malamatenia Lamprinou, Ioannis Dardalas, Ioannis S. Vizirianakis · 2023 · Pharmaceutics
  17. Engineered tRNAs suppress nonsense mutations in cells and in vivo
    Suki Albers, Elizabeth C. Allen, Nikhil Bharti, Marcos Davyt, Disha Joshi, Carlos G. Pérez‐García, Leonardo A. Santos, Rajesh Mukthavaram, Miguel Angel Delgado-Toscano, Brandon Molina et al. · 2023 · Nature
  18. Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich’s ataxia
    Nabhan, Joseph F., Wood, Kristy M., Rao, Varada P., Morin, Jeffrey, Bhamidipaty, Surya, LaBranche, Timothy P., Gooch, Renea L., Bozal, Fazli, Bulawa, Christine E., Guild, Braydon C. · 2016 · Scientific Reports
  19. Nanomedicine-Based Approaches for mRNA Delivery
    Uchida, Satoshi, Perche, Federico, Pichon, Chantal, Cabral, Horacio · 2020 · Molecular Pharmaceutics
  20. A Systematic Study of Unsaturation in Lipid Nanoparticles Leads to Improved mRNA Transfection In Vivo
    Sang M. Lee, Qiang Cheng, Xueliang Yu, Shuai Liu, Lindsay T. Johnson, Daniel J. Siegwart · 2020 · Angewandte Chemie International Edition
  21. Programmable protein circuit design
    Zibo Chen, Michael B. Elowitz · 2021 · Cell
  22. High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models
    Lulu Xue, Alex G. Hamilton, Gan Zhao, Zebin Xiao, Rakan D. El-Mayta, Xuexiang Han, Ningqiang Gong, Xinhong Xiong, Junchao Xu, Christian G. Figueroa‐Espada et al. · 2024 · Nature Communications
  23. Immunogenicity of In Vitro -Transcribed RNA
    Xin Ni Mu, Sun Hur · 2021 · Accounts of Chemical Research
  24. Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
    Jisun Lee, Matthew Charles Woodruff, Eui Ho Kim, Jae‐Hwan Nam · 2023 · Experimental & Molecular Medicine
  25. Synthesis of low immunogenicity RNA with high-temperature in vitro transcription
    Monica Z. Wu, Haruichi Asahara, George Tzertzinis, Bijoyita Roy · 2020 · RNA
  26. Codon optimality-mediated mRNA degradation: Linking translational elongation to mRNA stability
    Haneui Bae, Jeff M. Coller · 2022 · Molecular Cell
  27. 2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2
    Mehmet Altay Ünal, Fatma Bayrakdar, Laura Fusco, Ömür Beşbinar, Christopher E. Shuck, Süleyman Yalçın, Mine Turktas Erken, Aykut Özkul, Cansu Gürcan, Oguzhan Panatli et al. · 2021 · Nano Today
  28. Injectable Immunotherapeutic Hydrogel Containing RNA-Loaded Lipid Nanoparticles Reshapes Tumor Microenvironment for Pancreatic Cancer Therapy
    Chao Gao, Keman Cheng, Yao Li, Ruining Gong, Xiao Zhao, Guangjun Nie, He Ren · 2022 · Nano Letters
  29. Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study
    Li, Jingxin, Hui, Aimin, Zhang, Xiang, Yang, Yumei, Tang, Rong, Ye, Huayue, Ji, Ruiru, Lin, Mei, Zhu, Zhongkui, Türeci, Özlem et al. · 2021 · Nature Medicine
  30. Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response
    Jessica Foster, Namrata Choudhari, Jessica Perazzelli, Julie Storm, Ted J. Hofmann, Payal Jain, Phillip B. Storm, Norbert Pardi, Drew Weissman, Angela Jae Waanders et al. · 2018 · Human Gene Therapy
  31. Novel Vaccine Technologies in Veterinary Medicine: A Herald to Human Medicine Vaccines
    Virginia Aida, Vasilis C. Pliasas, Peter J. Neasham, J. Fletcher North, Kirklin L. McWhorter, Sheniqua R. Glover, Constantinos S. Kyriakis · 2021 · Frontiers in Veterinary Science
  32. Induction of robust B cell responses after influenza mRNA vaccination Is accompanied by circulating hemagglutinin-specific ICOS+ PD-1+ CXCR3+ T follicular helper cells
    Lindgren, Gustaf, Ols, Sebastian, Liang, Frank, Thompson, Elizabeth A., Lin, Ang, Hellgren, Fredrika, Bahl, Kapil, John, Shinu, Yuzhakov, Olga, Hassett, Kimberly J. et al. · 2017 · Frontiers in Immunology
  33. mRNA Vaccines Encoding the HA Protein of Influenza A H1N1 Virus Delivered by Cationic Lipid Nanoparticles Induce Protective Immune Responses in Mice
    Zhuang, Xinyu, Qi, Yanxin, Wang, Maopeng, Yu, Ning, Nan, Fulong, Zhang, He, Tian, Mingyao, Li, Chang, Lu, Huijun, Jin, Ningyi · 2020 · Vaccines
  34. Genome editing at the crossroads of delivery, specificity, and fidelity
    Ignazio Maggio, Manuel A.F.V. Gonçalves · 2015 · Trends in biotechnology
  35. Dual Roles of Metal–Organic Frameworks as Nanocarriers for miRNA Delivery and Adjuvants for Chemodynamic Therapy
    Huaixin Zhao, Taotao Li, Chi Yao, Zi Gu, Chunxia Liu, Jiahe Li, Dayong Yang · 2021 · ACS Applied Materials & Interfaces
  36. Review: RNA-based diagnostic markers discovery and therapeutic targets development in cancer
    Hongbo Wang, Qinghai Meng, Jinjun Qian, Muxi Li, Chunyan Gu, Ye Yang · 2022 · Pharmacology & Therapeutics
  37. The immunostimulatory nature of mRNA lipid nanoparticles
    Preeti Sharma, Daniek Hoorn, Anjaiah Aitha, Dor Breier, Dan Peer · 2024 · Advanced Drug Delivery Reviews
  38. Chitosan in Non-Viral Gene Delivery: Role of Structure, Characterization Methods, and Insights in Cancer and Rare Diseases Therapies
    Beatriz Santos-Carballal, Elena Fernández Fernández, Francisco M. Goycoolea · 2018 · Polymers
  39. Cationic Liposomes as Vectors for Nucleic Acid and Hydrophobic Drug Therapeutics
    Kai K. Ewert, Pablo Scodeller, Lorena Simón‐Gracia, Victoria M. Steffes, Emily A. Wonder, Tambet Teesalu, Cyrus R. Safinya · 2021 · Pharmaceutics
  40. Nanoplatforms for mRNA Therapeutics
    Meng, Chaoyang, Chen, Zhe, Li, Gang, Welte, Thomas, Shen, Haifa · 2021 · Advanced Therapeutics
  41. The changing model of big pharma: impact of key trends
    Ajay Gautam, Xiaogang Pan · 2015 · Drug Discovery Today
  42. Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells
    Sandra Van Lint, Dries Renmans, Katrijn Broos, Lode Goethals, Sarah K. Maenhout, Daphné Benteyn, Cleo Goyvaerts, Stephanie Du Four, Kevin Van der Jeught, Lukasz Bialkowski et al. · 2016 · Cancer Immunology Research
  43. Lipid carriers for mRNA delivery
    Wanting Zhang, Yuxin Jiang, Yonglong He, Hamza Boucetta, Jun Wu, Zhongjian Chen, Wei He · 2022 · Acta Pharmaceutica Sinica B
  44. Local Delivery of <i>Ox40l</i> , <i>Cd80</i> , and <i>Cd86</i> mRNA Kindles Global Anticancer Immunity
    Haabeth, Ole Audun Werner, Blake, Timothy R., McKinlay, Colin J., Tveita, Anders A., Sallets, Adrienne, Waymouth, Robert M., Wender, Paul A., Levy, Ronald · 2019 · Cancer Research
  45. Responsive Nanocarriers as an Emerging Platform for Cascaded Delivery of Nucleic Acids to Cancer
    Yang Liu, Cong‐Fei Xu, Shoaib Iqbal, Xianzhu Yang, Jun Wang · 2017 · Advanced Drug Delivery Reviews
  46. The roles of polymers in mRNA delivery
    Pei Huang, Hongzhang Deng, Yongfeng Zhou, Xiaoyuan Shawn Chen · 2022 · Matter
  47. mRNA Delivery by a pH‐Responsive DNA Nano‐Hydrogel
    Xin Fu, Tianshu Chen, Yuchen Song, Chang Feng, Huinan Chen, Qianqian Zhang, Guifang Chen, Xiaoli Zhu · 2021 · Small
  48. Customizable Lipid Nanoparticle Materials for the Delivery of siRNAs and mRNAs
    Owen S. Fenton, Kevin J. Kauffman, Rebecca L. McClellan, James C. Kaczmarek, Manhao D. Zeng, Jason L. Andresen, Luke H. Rhym, Michael W. Heartlein, Frank DeRosa, Daniel G. Anderson · 2018 · Angewandte Chemie International Edition
  49. Nanoparticle formulated vaccines: opportunities and challenges
    Pingsai Lung, Jingnan Yang, Quan Li · 2020 · Nanoscale
  50. Graphene Oxide-Upconversion Nanoparticle Based Optical Sensors for Targeted Detection of mRNA Biomarkers Present in Alzheimer’s Disease and Prostate Cancer
    Patrick Vilela, Afaf Helmy El-Sagheer, Timothy M. Millar, Tom P Brown, Otto L. Muskens, Antonios G. Kanaras · 2016 · ACS Sensors
  51. Clinical delivery of circular RNA: Lessons learned from RNA drug development
    Tiana L. Young, Kevin Chang Wang, Andrew Varley, Bowen Li · 2023 · Advanced Drug Delivery Reviews
  52. Biomedical applications of mRNA nanomedicine
    Xiong, Qingqing, Lee, Gha Young, Ding, Jianxun, Li, Wenliang, Shi, Jinjun · 2018 · Nano Research
  53. COVID-19 vaccines for patients with cancer: benefits likely outweigh risks
    Joyce K. Hwang, Tian Zhang, Andrew Zhuang Wang, Zihai Li · 2021 · Journal of Hematology & Oncology
  54. Branched chemically modified poly(A) tails enhance the translation capacity of mRNA
    Hongyu Chen, Dangliang Liu, Jianting Guo, Abhishek J. Aditham, Yiming Zhou, Jiakun Tian, Shuchen Luo, Jingyi Ren, Alvin Hsu, Jiahao Huang et al. · 2024 · Nature Biotechnology
  55. Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
    Xin Bai, Qijing Chen, Fengqiao Li, Yilong Teng, Maoping Tang, Jia Huang, Xiaoyang Xu, Xue‐Qing Zhang · 2024 · Nature Communications
  56. Heartworm disease – Overview, intervention, and industry perspective
    Sandra Noack, John Lyle Harrington, Doug S. Carithers, Ronald Kaminsky, Paul M. Selzer · 2021 · International Journal for Parasitology Drugs and Drug Resistance
  57. The nano delivery systems and applications of mRNA
    Mingyuan Li, Yuan Li, Shiqin Li, Lin Jia, Haomeng Wang, Meng Li, Jie Deng, Ali Zhu, Liqiao Ma, Weihong Li et al. · 2021 · European Journal of Medicinal Chemistry
  58. Novel approaches for the design, delivery and administration of vaccine technologies
    Wallis, J, Shenton, D P, Carlisle, R C · 2019 · Clinical and Experimental Immunology
  59. mRNA-Based Vaccines
    Frank Kowalzik, Daniel Schreiner, Christian Jensen, Daniel Teschner, Stephan Gehring, Fred Zepp · 2021 · Vaccines
  60. mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy
    Zhuoya Deng, Yuying Tian, Jianxun Song, Guangwen An, Penghui Yang · 2022 · Frontiers in Immunology
  61. RNA therapeutics: updates and future potential
    Caroline Zhang, Biliang Zhang · 2022 · Science China Life Sciences
  62. Clinical advances of mRNA vaccines for cancer immunotherapy
    Alexey V. Yaremenko, Muhammad Muzamil Khan, Xueyan Zhen, Yan Tang, Wei Tao · 2025 · Med
  63. Type I interferons interfere with the capacity of mRNA lipoplex vaccines to elicit cytolytic T cell responses
    De Beuckelaer, Ans, Pollard, Charlotte, Van Lint, Sandra, Roose, Kenny, Van Hoecke, Lien, Naessens, Thomas, Udhayakumar, Vimal Kumar, Smet, Muriel, Sanders, Niek, Lienenklaus, Stefan et al. · 2016 · Molecular Therapy
  64. Precision medicine: In vivo CAR therapy as a showcase for receptor-targeted vector platforms
    Alexander Michels, Naphang Ho, C. Buchholz · 2022 · Molecular Therapy
  65. Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines
    Nakamura, Takashi, Sato, Yusuke, Yamada, Yuma, Abd Elwakil, Mahmoud M., Kimura, Seigo, Younis, Mahmoud A., Harashima, Hideyoshi · 2022 · Advanced Drug Delivery Reviews
  66. Metal–Drug Coordination Nanoparticles and Hydrogels for Enhanced Delivery
    Ka‐Ying Wong, Zhenyu Nie, Man‐Sau Wong, Yang Wang, Juewen Liu · 2024 · Advanced Materials
  67. Messenger RNA delivery of a cartilage-anabolic transcription factor as a disease-modifying strategy for osteoarthritis treatment
    H. Aini, K. Itaka, Ayano Fujisawa, H. Uchida, S. Uchida, S. Fukushima, K. Kataoka, Taku Saito, U. Chung, Shinsuke Ohba · 2016 · Scientific Reports
  68. Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic delivery
    Lulu Xue, Gan Zhao, Ningqiang Gong, Xuexiang Han, Sarah J. Shepherd, Xinhong Xiong, Zebin Xiao, Rohan Palanki, Junchao Xu, Kelsey L. Swingle et al. · 2024 · Nature Nanotechnology
  69. Messenger RNA therapy for rare genetic metabolic diseases
    Pedro Berraondo, Paolo G.V. Martini, Matias Antonio Avila, Antonio Fontanellas · 2019 · Gut
  70. Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza
    Chivukula, Sudha, Plitnik, Timothy, Tibbitts, Timothy, Karve, Shrirang, Dias, Anusha, Zhang, Donghui, Goldman, Rebecca, Gopani, Hardip, Khanmohammed, Asad, Sarode, Ashish et al. · 2021 · npj Vaccines
  71. Endocytic Profiling of Cancer Cell Models Reveals Critical Factors Influencing LNP-Mediated mRNA Delivery and Protein Expression
    Edward John Sayers, Samantha E. Peel, Anna Schantz, R. England, Maya Beano, Stephanie M. Bates, Arpan S. Desai, Sanyogitta Puri, Marianne B. Ashford, Arwyn Tomos Jones · 2019 · Molecular Therapy
  72. Photochemical Internalization for Intracellular Drug Delivery. From Basic Mechanisms to Clinical Research
    Waseem Jerjes, Theodossis Athanassios Theodossiou, Henry Hirschberg, Anders Høgset, Anette Weyergang, Pål Kristian Selbo, Zaid Hamdoon, Colin Hopper, Kristian Berg · 2020 · Journal of Clinical Medicine
  73. From structural design to delivery: mRNA therapeutics for cancer immunotherapy
    Feng Zhou, Lujia Huang, Shiqin Li, Wenfang Yang, Fangmin Chen, Zhixiong Cai, Xiaolong Liu, Wujun Xu, Vesa‐Pekka Lehto, Ulrich Lächelt et al. · 2023 · Exploration
  74. Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases
    Trepotec, Zeljka, Lichtenegger, Eva, Plank, Christian, Aneja, Manish K., Rudolph, Carsten · 2019 · Molecular Therapy
  75. Current RNA-based Therapeutics in Clinical Trials
    Lingyan Zhou, Zhou Qin, Yanghui Zhu, Zhiyao He, Ting Xu · 2019 · Current Gene Therapy
  76. Machine Learning for Designing Next-Generation mRNA Therapeutics
    Sebastian M. Castillo-Hair, Georg Seelig · 2021 · Accounts of Chemical Research
  77. Nucleic acid nanoassembly-enhanced RNA therapeutics and diagnosis
    Mengnan Zhao, Rui Wang, Kunmeng Yang, Yuhong Jiang, Yachen Peng, Yuke Li, Zhen Zhang, Jianxun Ding, Sanjun Shi · 2022 · Acta Pharmaceutica Sinica B
  78. Nanotechnology-empowered vaccine delivery for enhancing CD8+ T cells-mediated cellular immunity
    Guangna Liu, Motao Zhu, Xiao Zhao, Guangjun Nie · 2021 · Advanced Drug Delivery Reviews
  79. Advances in Therapeutic Cancer Vaccines
    Karrie Ka Wai Wong, Aileen W. Li, David J. Mooney, Glenn Dranoff · 2016 · Advances in immunology
  80. Recent Advancements in Nanomedicine for ‘Cold’ Tumor Immunotherapy
    Qinjun Chen, Tao Sun, Chen Jiang · 2021 · Nano-Micro Letters
  81. mRNA delivery systems for cancer immunotherapy: Lipid nanoparticles and beyond
    Mariona Estapé Sentí, Lucía García del Valle, Raymond Michel Schiffelers · 2024 · Advanced Drug Delivery Reviews
  82. Non-immunotherapy application of LNP-mRNA: Maximizing efficacy and safety
    Vlatkovic, Irena · 2021 · Biomedicines
  83. Evading innate immunity in nonviral mRNA delivery: don't shoot the messenger.
    Devoldere, Joke, Dewitte, Heleen, De Smedt, Stefaan C., Remaut, Katrien · 2016 · Drug Discovery Today
  84. Synthetic mRNA capping
    Fabian Muttach, Nils Muthmann, Andrea Rentmeister · 2017 · Beilstein Journal of Organic Chemistry
  85. The role of N6-methyladenosine mRNA in the tumor microenvironment
    Min Li, Xuan Zha, Shengjun Wang · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  86. Lipid nanoparticle mRNA systems containing high levels of sphingomyelin engender higher protein expression in hepatic and extra-hepatic tissues
    Nisha Chander, Genc Basha, Miffy H. Y. Cheng, Dominik Witzigmann, Pieter R. Cullis · 2023 · Molecular Therapy — Methods & Clinical Development
  87. Screening for lipid nanoparticles that modulate the immune activity of helper T cells towards enhanced antitumour activity
    Yining Zhu, Jingyao Ma, Ruochen Shen, Jinghan Lin, Shuyi Li, Xiaoya Lu, Jessica L. Stelzel, Jiayuan Kong, Leonardo Cheng, Ivan Vuong et al. · 2023 · Nature Biomedical Engineering
  88. Systemic mRNA delivery to the lungs by functional polyester-based carriers
    Yan, Yunfeng, Xiong, Hu, Zhang, Xinyi, Cheng, Qiang, Siegwart, Daniel J. · 2017 · Biomacromolecules
  89. Poly(glycoamidoamine) Brushes Formulated Nanomaterials for Systemic siRNA and mRNA Delivery in Vivo
    Yizhou Dong, J. Robert Dorkin, Weiheng Wang, Philip Chang, Matthew J. Webber, Benjamin C. Tang, Junghoon Yang, Inbal Abutbul Ionita, Dganit Danino, Frank DeRosa et al. · 2016 · Nano Letters
  90. Wwp2 maintains cartilage homeostasis through regulation of Adamts5
    Sho Mokuda, Ryo Nakamichi, Tokio Matsuzaki, Yoshiaki Ito, Tempei Sato, Kohei Miyata, Masafumi Inui, Merissa Olmer, Eiji Sugiyama, Martin Lotz et al. · 2019 · Nature Communications
  91. Translating Nanoparticulate-Personalized Cancer Vaccines Into Clinical Applications: Case Study With RNA-Lipoplexes for the Treatment of Melanoma
    Stephan Grabbe, Heinrich Haas, Mustafa Diken, Lena M. Kranz, Peter Langguth, Uğur Şahin · 2016 · Nanomedicine
  92. An overview of rational design of mRNA-based therapeutics and vaccines
    To, Kenneth K.W., Cho, William C.S. · 2021 · Expert Opinion on Drug Discovery
  93. mRNA: Fulfilling the Promise of Gene Therapy
    Drew Weissman, Katalin Karikó · 2015 · Molecular Therapy
  94. Systemic delivery of mRNA and DNA to the lung using polymer-lipid nanoparticles
    James C. Kaczmarek, Asha Kumari Patel, Luke H. Rhym, Umberto Capasso Palmiero, Balkrishen Bhat, Michael W. Heartlein, Frank DeRosa, Daniel G. Anderson · 2021 · Biomaterials
  95. Oral mRNA delivery using capsule-mediated gastrointestinal tissue injections
    Alex Abramson, Ameya R. Kirtane, Yunhua Shi, Grace Zhong, Joy E. Collins, Siddartha M. Tamang, Keiko Ishida, Alison M. Hayward, Jacob Wainer, Netra Unni Rajesh et al. · 2022 · Matter
  96. Type I Interferons Modulate CD8 + T Cell Immunity to mRNA Vaccines
    Ans De Beuckelaer, Johan Grooten, Stefaan De Koker · 2017 · Trends in Molecular Medicine
  97. In Vitro Engineering Chimeric Antigen Receptor Macrophages and T Cells by Lipid Nanoparticle-Mediated mRNA Delivery
    Zhongfeng Ye, Jinjin Chen, Xuewei Zhao, Yamin Li, Joseph Harmon, Changfeng Huang, Jianzhu Chen, Qiaobing Xu · 2022 · ACS Biomaterials Science & Engineering
  98. Nanoparticle cancer vaccines: Design considerations and recent advances
    Jingjing Liu, Lei Miao, Jiying Sui, Yanyun Hao, Guihua Huang · 2019 · Asian Journal of Pharmaceutical Sciences
  99. Microfluidic Cell Stretching for Highly Effective Gene Delivery into Hard-to-Transfect Primary Cells
    Jeongsoo Hur, Inae Park, Kyung Min Lim, Junsang Doh, Ssang‐Goo Cho, Aram J. Chung · 2020 · ACS Nano
  100. Advances in mRNA non-viral delivery approaches
    Maria Luigia Ibba, Giuseppe Ciccone, Carla Lucia Esposito, Silvia Catuogno, Paloma H. Giangrande · 2021 · Advanced Drug Delivery Reviews